{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T06:27:10Z","timestamp":1789194430525,"version":"build-2803163510"},"reference-count":33,"publisher":"Society of Nuclear Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2024,9,19]]},"DOI":"10.2967\/jnumed.124.268217","type":"journal-article","created":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T20:20:14Z","timestamp":1729801214000},"page":"jnumed.124.268217","source":"Crossref","is-referenced-by-count":7,"title":["Intraarterial Administration of Peptide Receptor Radionuclide Therapy in Patients with Advanced Meningioma: Initial Safety and Efficacy"],"prefix":"10.2967","author":[{"given":"Adriana","family":"Amerein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malte","family":"Kircher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"G\u00e4ble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Krebold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Rinscheid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Viering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian H.","family":"Pfob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph A.","family":"Bundschuh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Behrens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur JAT","family":"Braat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ansgar","family":"Berlis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantin","family":"Lapa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2024,10,24]]},"reference":[{"key":"2024102413200559000_jnumed.124.268217v1.1","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/noad149","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2016\u20132020","volume":"25","author":"Ostrom","year":"2023","journal-title":"Neuro-oncol."},{"key":"2024102413200559000_jnumed.124.268217v1.2","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nox158"},{"key":"2024102413200559000_jnumed.124.268217v1.3","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noab150"},{"key":"2024102413200559000_jnumed.124.268217v1.4","doi-asserted-by":"publisher","DOI":"10.1007\/s00701-012-1611-y"},{"key":"2024102413200559000_jnumed.124.268217v1.5","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nos013"},{"key":"2024102413200559000_jnumed.124.268217v1.6","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1997.86.5.0793"},{"key":"2024102413200559000_jnumed.124.268217v1.7","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1586\/ern.11.38","article-title":"Medical treatment of recurrent meningiomas","volume":"11","author":"Chamberlain","year":"2011","journal-title":"Expert Rev Neurother."},{"key":"2024102413200559000_jnumed.124.268217v1.8","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/not330"},{"key":"2024102413200559000_jnumed.124.268217v1.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.03.304"},{"key":"2024102413200559000_jnumed.124.268217v1.10","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-015-1459-3"},{"key":"2024102413200559000_jnumed.124.268217v1.11","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.249607"},{"key":"2024102413200559000_jnumed.124.268217v1.12","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/now060"},{"key":"2024102413200559000_jnumed.124.268217v1.13","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s00259-022-06044-9","article-title":"Efficacy and safety of peptide receptor radionuclide therapy with [177Lu]Lu-DOTA-TATE in 15 patients with progressive treatment-refractory meningioma","volume":"50","author":"Minczeles","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2024102413200559000_jnumed.124.268217v1.14","doi-asserted-by":"publisher","DOI":"10.1186\/1748-717X-7-99"},{"key":"2024102413200559000_jnumed.124.268217v1.15","first-page":"29","article-title":"Long-term results of multimodal peptide receptor radionuclide therapy and fractionated external beam radiotherapy for treatment of advanced symptomatic meningioma","volume":"22","author":"Hartrampf","year":"2020","journal-title":"Clin Transl Radiat Oncol."},{"key":"2024102413200559000_jnumed.124.268217v1.16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1607427"},{"key":"2024102413200559000_jnumed.124.268217v1.17","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-002-1050-8"},{"key":"2024102413200559000_jnumed.124.268217v1.18","doi-asserted-by":"publisher","DOI":"10.1089\/cbr.2012.1195"},{"key":"2024102413200559000_jnumed.124.268217v1.19","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1007\/s12149-021-01674-9","article-title":"Safety and efficacy of peptide receptor radionuclide therapy with 177Lu-DOTA0-Tyr3-octreotate in combination with amino acid solution infusion in Japanese patients with somatostatin receptor-positive, progressive neuroendocrine tumors","volume":"35","author":"Kobayashi","year":"2021","journal-title":"Ann Nucl Med."},{"key":"2024102413200559000_jnumed.124.268217v1.20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4103\/1450-1147.89779","article-title":"Improved quality of life in patients treated with peptide radionuclides","volume":"10","author":"Traub-Weidinger","year":"2011","journal-title":"World J Nucl Med."},{"key":"2024102413200559000_jnumed.124.268217v1.21","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A1034"},{"key":"2024102413200559000_jnumed.124.268217v1.22","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19980529)76:5<620::AID-IJC2>3.0.CO;2-S"},{"key":"2024102413200559000_jnumed.124.268217v1.23","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1007\/s00270-019-02262-1","article-title":"Will 177Lu-DOTATATE treatment become more effective in salvage meningioma patients, when boosting somatostatin receptor saturation? A promising case on intra-arterial administration","volume":"42","author":"Braat","year":"2019","journal-title":"Cardiovasc Intervent Radiol."},{"key":"2024102413200559000_jnumed.124.268217v1.24","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.262491"},{"key":"2024102413200559000_jnumed.124.268217v1.25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-13467-9"},{"key":"2024102413200559000_jnumed.124.268217v1.26","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-012-2330-6"},{"key":"2024102413200559000_jnumed.124.268217v1.27","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noy137"},{"key":"2024102413200559000_jnumed.124.268217v1.28","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-014-2893-5"},{"key":"2024102413200559000_jnumed.124.268217v1.29","doi-asserted-by":"publisher","DOI":"10.1089\/cbr.2009.0641"},{"key":"2024102413200559000_jnumed.124.268217v1.30","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(96)90090-3"},{"key":"2024102413200559000_jnumed.124.268217v1.31","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.114.147256"},{"key":"2024102413200559000_jnumed.124.268217v1.32","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-009-1115-z"},{"key":"2024102413200559000_jnumed.124.268217v1.33","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/neuonc\/noab243","article-title":"Trabectedin for recurrent WHO grade 2 or 3 meningioma: a randomized phase II study of the EORTC brain tumor group (EORTC-1320-BTG)","volume":"24","author":"Preusser","year":"2022","journal-title":"Neuro-oncol."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.124.268217","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T20:20:18Z","timestamp":1729801218000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.124.268217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,24]]},"references-count":33,"alternative-id":["10.2967\/jnumed.124.268217"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.124.268217","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,24]]}}}